Comments on &ldquo;Emodin-Conjugated PEGylation of Fe<sub>3</sub>O<sub>4</sub> Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer&rdquo; [Letter]

Xin Wang

doi:10.2147/IJN.S357154

open access to scientific and medical research

Back to Journals » International Journal of Nanomedicine » Volume 17

Letter

Comments on “Emodin-Conjugated PEGylation of Fe₃O₄ Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer” [Letter]

Total article views		HTML views	PDF downloads	Totals
3,456	Dovepress*	3,394+	171	3,565
	PubMed Central*	62	20	82
	Totals	3,456	191	3,647
*Since 6 April 2022

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
2	0	0	0	1	1

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.

Comments on “Emodin-Conjugated PEGylation of Fe3O4 Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer” [Letter]

Comments on “Emodin-Conjugated PEGylation of Fe₃O₄ Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer” [Letter]